miR-375 is a highly abundant miRNA in Merkel cell carcinoma (MCC), in other cancers it 16 acts either as a tumor suppressor or oncogene. While free-circulating miR-375 serves as surrogate 17 marker for tumor burden in patients with advanced MCC, its function within MCC cells has not 18 been established. Nearly complete miR-375 knockdown in MCC cell lines was achieved using 19 antagomiRs via nucleofection. Neither cell viability, growth characteristics nor morphology were 20 altered by this knockdown. miR-375 target genes and related signaling pathways were determined 21 using ENCORI revealing Hippo signaling and EMT-related genes likely to be regulated. Thus, their 22 expression was analyzed by multiplexed qRT-PCR after miR-375 knockdown demonstrating only a 23 limited change in expression. In summary, highly effective miR-375 knockdown in classical MCC 24 cell lines did neither significantly change cell viability, morphology, nor oncogenic signaling 25 pathways. These observations render miR-375 an unlikely intracellular oncogene in MCC cells, thus 26 suggesting to address likely functions of miR-375 for intercellular communication of MCC. 28 29 1. Introduction 30 Merkel cell carcinoma (MCC) is an aggressive skin cancer. Risk factors for MCC include advanced
We were able to confirm our previous observation that miR-375 knockdown has no major impact on 83 either cell proliferation, survival, growth characteristics or cell morphology ( Fig.2 and Suppl. Fig. 2,   84 3). Notably, even the highly effective miR-375 knockdown did not alter morphologic appearance as 85 cells still show a neuroendocrine growth pattern as loose spheroids or single cells, which was 86 identical to the growth pattern in cells transfected with unspecific control antagomiRs ( Fig. 2a, b ).
87
Furthermore, neither the metabolic nor proliferative activity was affected by the miR-375 knockdown 88 ( Fig. 2c, d) . While the harsh transfection conditions for the highly efficient miR-375 knockdown 89 inhibited the proliferation of the MCC cells per se -indeed, we observed around 40% apoptotic cells 90 24h after nucleofection in both WaGa and PeTa -no difference was observed in MCC cells transfected 91 with miR-375 antagomiRs or negative control ( Fig. 2e , f and Suppl. Fig. 3 ). Sequential analyses on 92 days 3 and 5 after transfection further supported that miR-375 knockdown had no specific impact on To further investigate the role of miR-375 in MCCs, we predicted target genes of this miRNA using 105 the miRNA target prediction tool ENCORI. This tool has the advantage that the results can be filtered 106 for experimentally validated target genes. Nevertheless, more than 3000 target genes were predicted, 107 thus, top ranking 500 genes were selected for further analysis (Suppl . Table 1 ). Gene Ontology (GO) 5 of 12 analysis shows that miR-375 target genes contribute to several signaling pathways, including Golgi 109 transport, cell junction assembly, Hippo signaling and neuron differentiation ( Fig. 3a) . To test the 110 relevance of these predictions in MCC, we reanalyzed previously published transcriptome 111 microarray data of MCC cell lines [29] . Of this data set, four MCC cell lines were selected according 112 to their miR-375 expression level: WaGa and MKL-1 with high and, MCC13 and MCC26 with low 113 miR-375 expression [14] . Gene Set Enrichment Analysis (GSEA) confirmed that particularly genes 114 related in focal adhesion signaling pathway were lower expressed in cell lines with high miR-375 115 expression ( Fig. 3b ). Moreover, focal adhesion signaling pathways included most of the 116 experimentally confirmed miR-375 target genes; this notion applies also for miR-375 target genes Since our in-silico analysis suggested that miR-375 may regulate Hippo and EMT-related signaling 128 pathways, we tested this hypothesis by miR-375 knockdown experiments together with qRT-PCR 129 based expression arrays for Hippo and EMT signaling related genes. These experiments, however, 130 did not reveal any statistically significant changes in gene expression of compounds of these two 131 signaling pathways in MCC cell lines upon miR-375 knockdown. In detail, miR-375 knockdown only 132 resulted in a non-significant (i.e., less than +/-two-fold changes in expression) upregulation of eleven 133 (11/84, 13.1%) and downregulation of four genes (4/84, 4.8%) related to the Hippo signaling pathway, 134 as well as a non-significant upregulation of eleven (11/84, 13.1%) and downregulation of three genes 135 (3/84, 3.5%) with respect to EMT-signaling pathway (Fig. 4 , Suppl. Table 2 ). 
146
Despite the fact that miR-375 is highly expressed in classical MCC cell lines and MCC tumors, 147 its function in MCC is not clear. To study the relevance of miR-375 on intracellular signaling in detail,
148
we performed a series of knockdown experiments using specific antagomiRs. Surprisingly, even 149 nearly complete knockdown of miR-375 expression neither affected proliferation, growth pattern nor 150 cell morphology. Similarly, the impact of miR-375 knockdown on expression of Hippo and EMT 7 of 12 signaling pathway related genes, i.e., pathways predicted to be regulated by miR-375, were only 152 marginal. These results taken together with our previous observations that miR-375 is present in 153 MCC cell line conditioned medium, in sera of preclinical xenotransplantation animal models and in 154 sera of MCC patients [14] suggests that, miR-375 may rather serve intercellular than intracellular 155 signaling in MCC. Indeed, miR-375 was recently characterized as an exosomal shuttle miRNA [31, 32] .
156
In previous reports, miR-375 knockdown or inhibition in MCC cell lines resulted in different 
168
Knockdown of abundant miRNAs can be challenging [34] . AntagomiRs have been employed for 169 miRNA silencing in vitro and in vivo via miRNA degradation for years [34, 35] . In our study, we 170 introduced the respective antagomiRs with two different transfection conditions, which revealed that 171 nuclear transfection was much more efficient and only this method succeeded in a nearly complete 172 knockdown up to five days post-transfection. To be noted, we observed a slight increase in miR-375 173 expression over time after antagomiRs transfection. Thus, the described method is very effective for 174 short-term knockdown, but not for long-term inhibition (Suppl. Fig. S2 ). Besides miRNA antagomiRs, 
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In summary, we demonstrate that even the highly efficient, almost complete knockdown of the 
